Literature DB >> 8033070

Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation.

C C Yit1, N P Das.   

Abstract

Several classes of plant polyphenols namely, flavonoids, chalcones and coumarins exhibited varying degrees of inhibition on the cell proliferation of human colon adenocarcinoma cell line 220.1. At the highest concentration tested (100 microM), many of the chalcones showed > 100% growth inhibition and their order of potency was butein > 2'-hydroxychalcone > 2-hydroxychalcone > 2',6'-dihydroxy-4'-methoxychalcone > 2',4-dihydroxychalcone with IC50 values of 1.75, 6.2, 7.5, 17, 23 microM, respectively. Butein (the most potent chalcone) at 2 microM concentration inhibited the incorporation of 14C-labelled thymidine, uridine and leucine into the colon cancer cells whilst 5-fluorouracil (5-FU, a chemotherapeutic drug) at 50 microM concentration could significantly inhibit only the uridine incorporation. The mode of cytotoxic action of butein was different from 5-FU but may be similar to colchicine, a known HeLa cell inhibitor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033070     DOI: 10.1016/0304-3835(94)90147-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling.

Authors:  Bokyung Sung; Sung-Gook Cho; Mingyao Liu; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2011-03-11       Impact factor: 7.396

2.  Dietary chalcones with chemopreventive and chemotherapeutic potential.

Authors:  Barbora Orlikova; Deniz Tasdemir; Frantisek Golais; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2011-02-04       Impact factor: 5.523

3.  Dihydroconiferyl Ferulate Isolated from Dendropanax morbiferus H.Lév. Suppresses Stemness of Breast Cancer Cells via Nuclear EGFR/c-Myc Signaling.

Authors:  Yu-Chan Ko; Ren Liu; Hu-Nan Sun; Bong-Sik Yun; Hack Sun Choi; Dong-Sun Lee
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-26

4.  Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1.

Authors:  Manoj K Pandey; Bokyung Sung; Kwang Seok Ahn; Bharat B Aggarwal
Journal:  Mol Pharmacol       Date:  2008-12-22       Impact factor: 4.436

5.  Generation of reactive oxygen species mediates butein-induced apoptosis in neuroblastoma cells.

Authors:  Ya-Hui Chen; Chi-Wei Yeh; Hui-Chen Lo; Shih-Li Su; You-Cheng Hseu; Li-Sung Hsu
Journal:  Oncol Rep       Date:  2012-01-12       Impact factor: 3.906

6.  Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.

Authors:  Lirui Zhang; Xiaofeng Yang; Xu Li; Chen Li; Le Zhao; Yuanyuan Zhou; Huilian Hou
Journal:  Int J Mol Med       Date:  2015-08-24       Impact factor: 4.101

Review 7.  Integrating traditional medicine into modern inflammatory diseases care: multitargeting by Rhus verniciflua Stokes.

Authors:  Ji Hye Kim; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Mediators Inflamm       Date:  2014-06-12       Impact factor: 4.711

8.  Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits.

Authors:  Shweta Sinha; Ajay Prakash; Bikash Medhi; Alka Sehgal; Daniela I Batovska; Rakesh Sehgal
Journal:  BMC Res Notes       Date:  2021-07-08

9.  The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts.

Authors:  Michael Samoszuk; Jenny Tan; Guillaume Chorn
Journal:  BMC Complement Altern Med       Date:  2005-03-09       Impact factor: 3.659

10.  Bidens pilosa L. (Asteraceae): Botanical Properties, Traditional Uses, Phytochemistry, and Pharmacology.

Authors:  Arlene P Bartolome; Irene M Villaseñor; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.